Iodide

Iodide

SCHEMBL2320529

CC[N+]1=C(C)C(C)(C)c2ccccc21.[I-]

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.65
HTT P42858 6/20 0.65
MEN1 O00255 5/20 0.65
LMNA P02545 5/20 0.65
KMT2A Q03164 5/20 0.65
THRB P10828 4/20 0.65
RECQL P46063 4/20 0.65
TDP1 Q9NUW8 2/20 0.65
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
S1PR2 O95136 1/20 0.39
POLB P06746 1/20 0.39
ALPG P10696 1/20 0.39
PKM P14618 1/20 0.39
XBP1 P17861 1/20 0.39
CRHBP P24387 1/20 0.39
RAB9A P51151 1/20 0.39
BLM P54132 1/20 0.39
CRHR2 Q13324 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL29658781 1.00 MAPT (0.65) MAPTHTTMEN1LMNAKMT2A
SCHEMBL29816480 0.98 KMT2A (0.62) MAPTHTTMEN1LMNAKMT2A
SCHEMBL2685093 0.98 KMT2A (0.62) MAPTHTTMEN1LMNAKMT2A
Bromide SCHEMBL31674705 0.96 MAPT (0.60) MAPTHTTMEN1LMNAKMT2A
Iodide SCHEMBL1628062 0.86 MAPT (0.49) MAPTHTTMEN1LMNAKMT2A
Iodide SCHEMBL30594274 0.86 MAPT (0.49) MAPTHTTMEN1LMNAKMT2A
SCHEMBL12056746 0.84 MAPT (0.46) MAPTHTTMEN1LMNAKMT2A
Iodide SCHEMBL31552581 0.83 MAPT (0.52) MAPTHTTMEN1LMNAKMT2A
Iodide SCHEMBL6864478 0.83 MAPT (0.52) MAPTHTTMEN1LMNAKMT2A
Bromide SCHEMBL18153296 0.82 MAPT (0.45) MAPTHTTMEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114656450-A Preparation method and application of N ^ N ^ N ligand with ultraviolet-visible absorption and fluorescence luminescence characteristics 中山大学 2022-06-24 CN claimed
CN-114478352-A Self-fixing small-molecule fluorescent probe and preparation method and application thereof 浙江工业大学 2022-05-13 CN claimed
CN-112294956-A Novel metal iridium photosensitizer and preparation method and application thereof 中山大学 2021-02-02 CN claimed
US-20260077067-A1 IMAGING COMPOUNDS FOR DETECTING OR IMAGING SENESCENT CELLS UNIV DUNDEE (GB) 2026-03-19 US disclosed
US-12496361-B2 Imaging compounds for detecting or imaging senescent cells UNIVERSITY OF DUNDEE (GB) 2025-12-16 US disclosed
EP-4649113-A1 IMAGING COMPOUNDS FOR DETECTING OR IMAGING SENESCENT CELLS University Of Dundee (GB) 2025-11-19 EP disclosed
US-20250114483-A1 IMAGING COMPOUNDS FOR DETECTING OR IMAGING SENESCENT CELLS UNIVERSITY OF DUNDEE (GB) 2025-04-10 US disclosed
WO-2024149992-A1 IMAGING COMPOUNDS FOR DETECTING OR IMAGING SENESCENT CELLS UNIVERSITY OF DUNDEE (GB) 2024-07-18 WO disclosed
CN-114656450-A Preparation method and application of N ^ N ^ N ligand with ultraviolet-visible absorption and fluorescence luminescence characteristics 中山大学 2022-06-24 CN disclosed
CN-114656450-A Preparation method and application of N ^ N ^ N ligand with ultraviolet-visible absorption and fluorescence luminescence characteristics 中山大学 2022-06-24 CN disclosed
CN-114478352-A Self-fixing small-molecule fluorescent probe and preparation method and application thereof 浙江工业大学 2022-05-13 CN disclosed
EP-0898596-B1 SQUARATE DYES AND THEIR USE IN FLUORESCENT SEQUENCING METHOD AMERSHAM PHARM BIOTECH UK LTD (GB) 2001-08-29 EP disclosed
US-6140494-A INCREASED WATER SOLUBILITY, INCREASED PHOTOSTABILITY, BRIGHTNESS AND THE POTENTIAL REDUCTION OF INTERACTIONS WITH SURROUNDINGS AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) 2000-10-31 US disclosed
EP-0898596-A1 SQUARATE DYES AND THEIR USE IN FLUORESCENT SEQUENCING METHOD Amersham Pharmacia Biotech UK Limited (GB) 1999-03-03 EP disclosed
WO-1997040104-A1 SQUARATE DYES AND THEIR USE IN FLUORESCENT SEQUENCING METHOD AMERSHAM PHARMACIA BIOTECH UK LIMITED (GB) 1997-10-30 WO disclosed
EP-0086230-B1 MEROCYANINE-CYANINE-MEROCYANINE (MCM) ELECTRICALLY PHOTOSENSITIVE COLORANTS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1987-01-07 EP disclosed
US-4463076-A Merocyanine-cyanine-merocyanine (MCM) electrically photosensitive colorants for photoelectrophoretic imaging EASTMAN KODAK COMPANY (US) 1984-07-31 US disclosed
EP-0086230-A4 MEROCYANINE-CYANINE-MEROCYANINE (MCM) ELECTRICALLY PHOTOSENSITIVE COLORANTS. EASTMAN KODAK CO (US) 1984-05-17 EP disclosed
EP-0086230-A1 MEROCYANINE-CYANINE-MEROCYANINE (MCM) ELECTRICALLY PHOTOSENSITIVE COLORANTS. EASTMAN KODAK CO (US) 1983-08-24 EP disclosed
WO-1983000752-A1 MEROCYANINE-CYANINE-MEROCYANINE (MCM) ELECTRICALLY PHOTOSENSITIVE COLORANTS LINK, STEVEN, GEORGE 1983-03-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260077067-A1 IMAGING COMPOUNDS FOR DETECTING OR IMAGING SENESCENT CELLS NR0B1, NR4A3, NCOA4 MAPT 2242/4885HTT 1136/4885MEN1 4003/4885
US-12496361-B2 Imaging compounds for detecting or imaging senescent cells LIMS1, GLA, TP53 MAPT 178/4885HTT 199/4885MEN1 502/4885
US-20250114483-A1 IMAGING COMPOUNDS FOR DETECTING OR IMAGING SENESCENT CELLS LIMS1, GLA, TP53 MAPT 178/4885HTT 199/4885MEN1 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.